ArticleOncoscience2023

Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.

Mohamed A Gouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.